Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. BMS promotes health equity globally and strives to increase access to life-saving medicines for populations disproportionately affected by serious diseases and conditions. They have joined the project consortium as an EFPIA partner.
Main contributions to the project:
- contributing to WP5’s Task 5.4 in developing a data management system
- contributing to WP5 Task 5.5, Access Control and Data Provenance
- part of the WP9 efforts in dissemination, sustainabilidy, and exploitation
- collaborators in WP7’s Task 7.4, aiding in the preparation of data analytic packages for obtaining scientific advice from the EMA and FDA
